UNITY fetal antigen test to be used in phase 3 nipocalimab trial
BillionToOne will allow its UNITY fetal antigen test to be used to test patients in the phase 3 trial evaluating the safety and efficacy of nipocalimab.
BillionToOne will allow its UNITY fetal antigen test to be used to test patients in the phase 3 trial evaluating the safety and efficacy of nipocalimab.
